周冬梅, 陈 刚, 郑雄伟, 朱伟峰, 陈宝珍. 112 例套细胞淋巴瘤临床病理分析*[J]. 中国肿瘤临床, 2015, 42(2): 82-86. DOI: 10.3969/j.issn.1000-8179.20141779
引用本文: 周冬梅, 陈 刚, 郑雄伟, 朱伟峰, 陈宝珍. 112 例套细胞淋巴瘤临床病理分析*[J]. 中国肿瘤临床, 2015, 42(2): 82-86. DOI: 10.3969/j.issn.1000-8179.20141779
Dongmei ZHOU, Gang CHEN, Xiongwei ZHENG, Weifeng ZHU, Baozhen CHEN. Clinicopathologic features of112 patients with mantle cell lymphoma[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2015, 42(2): 82-86. DOI: 10.3969/j.issn.1000-8179.20141779
Citation: Dongmei ZHOU, Gang CHEN, Xiongwei ZHENG, Weifeng ZHU, Baozhen CHEN. Clinicopathologic features of112 patients with mantle cell lymphoma[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2015, 42(2): 82-86. DOI: 10.3969/j.issn.1000-8179.20141779

112 例套细胞淋巴瘤临床病理分析*

Clinicopathologic features of112 patients with mantle cell lymphoma

  • 摘要: 目的:探讨套细胞淋巴瘤(mantle cell lymphoma,MCL )的临床病理特点。方法:收集112 例MCL 的临床及病理资料,采用免疫组织化学(Envision二步法)行相关抗体标记,荧光原位杂交技术(fluorescence in situ hybridization,FISH)对其中24例作IgH/CCND1 基因断裂检测。结果:112 例(包括2 例多形性和母细胞变亚型)均表达B 细胞相关抗原,94.6%(106/112)表达cyclinD1,92.9%(104/112)表达CD5。不同免疫表型的经典型MCL 的Ki-67及平均生存期无统计学差异(P>0.05)。 3 例CD5-的MCL未检测出IgH/CCND1 基因断裂,2 例经典型MCL 检测出IgH/CCND1 多倍体。结论:MCL 是一种具有特殊免疫表型的B 细胞淋巴瘤,多形性及母细胞变异型的预后较差,对特殊亚型的MCL 诊断有必要细分。

     

    Abstract: Objective:To explore the clinicopathologic features of 112 patients with mantle cell lymphoma (MCL). Methods:Da-ta from 112 MCL cases were collected, and immunohistochemical assay was conducted. A break in the CCND1 gene was detected by fluorescence in situ hybridization (FISH). The t-test was used in the statistical analysis. Results: All tumor cells in the 112 cases ex-pressed B cell-related antigen, including 1 blastoid subtype and 1 polymorphic subtype. Among all the cases, 106 expressed CD 5 and 104 expressed cyclinD1. A break in the CCND 1 gene was not found in 3 cases with CD 5-MCL. IgH/CCND 1 polyploid was found in 2 classical cases.Conclusion:MCL is a type of special immunophenotypic B-cell lymphoma. The prognoses of blastoid and polymorphic subtypes are poor. Special subtypes should be classified during diagnosis.

     

/

返回文章
返回